Covaxin gets DCGI nod to conduct clinical trials on children

Aaj Tak 2021-05-13

Views 76

The Drugs Controller General of India (DCGI) has approved Bharat Biotech’s Covaxin to conduct the Phase 2-3 clinical trials on children aged 2-18 years. Bharat Biotech will conduct the clinical trials on 525 healthy volunteers in the below 18 age group. Watch the video for more information.
Show more

Share This Video


Download

  
Report form
RELATED VIDEOS
Covaxin gets nod for emergency use for children aged 12-18
play
02:35

Covaxin gets nod for emergency use for children aged 12-18
AIIMS panel gives nod to human clinical trial of anti-coronavirus drug Covaxin
play
01:01

AIIMS panel gives nod to human clinical trial of anti-coronavirus drug Covaxin
Delhi AIIMS panel nod to human clinical trial of Covaxin
play
02:03

Delhi AIIMS panel nod to human clinical trial of Covaxin
Bharat Biotech to conduct Phase 3 trials for COVAXIN
play
00:37

Bharat Biotech to conduct Phase 3 trials for COVAXIN
Panel recommends phase 2/3 trials of Covaxin on children
play
12:38

Panel recommends phase 2/3 trials of Covaxin on children
AIIMS to begin screening children for Covaxin trials
play
17:51

AIIMS to begin screening children for Covaxin trials
AIIMS Delhi starts Covaxin trials on children
play
01:00

AIIMS Delhi starts Covaxin trials on children
India's first coronavirus vaccine gets nod for human trials
play
13:38

India's first coronavirus vaccine gets nod for human trials
Covaxin gets approval for children of 2-18 years age group
play
16:26

Covaxin gets approval for children of 2-18 years age group
Covid vaccine for children, DCGI gives approval to Covaxin
play
06:22

Covid vaccine for children, DCGI gives approval to Covaxin
No DCGI approval for Covaxin for kids yet: Health Ministry
play
01:04

No DCGI approval for Covaxin for kids yet: Health Ministry
Bharat Biotech vaccine Covaxin to get WHO nod soon?
play
03:37

Bharat Biotech vaccine Covaxin to get WHO nod soon?